Salesforce Friends ...
Health Care: Drugs
Chelsea Therapeutics International Ltd. (CHTP: NASDAQ)
$1.35 0.00 | 0.00%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.35 |
| 52 Week High | 6.06 |
| 52 Week Low | 1.25 |
| Avg. Daily Vol. (Mil) | 1.40 |
| Beta (3 year) | 1.29 |
| Share Related Items | |
| Mkt Cap (Mil) | 90.50 |
| Shares Out (Mil) | 67.04 |
| Float (Mil) | 49.99 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.20 |
| Current Ratio | 4.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 2.20 |
| Price/Cash Flow | -1.70 |
| Per Share Data | |
| Earnings | -0.82 |
| Sales | 0.00 |
| Book Value | 0.61 |
| Cash Flow | -0.78 |
| Business Summary | |
|---|---|
| Chelsea Therapeutics International, Ltd. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products. | |
| General Information | |
| 3530 Toringdon Way
Suite 200 Charlotte, NC 28277 |
|
| www.chelseatherapeutics.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 49 | |
| CEO: Dr. Simon Pedder,PhD | |
| Short Interest | |
| Current Month (Mil) | 6.87 |
| Previous Month (Mil) | 6.70 |
| Short Interest Ratio (Days) | 11.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -97.40 |
| Return on Investments | -126.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with CHTP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserLA
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Pharma Stocks With 100% ...
- UserLIGDOGS
- UserSharebuilder
Latest CHTP Headlines from TheStreet
- Chelsea Therapeutics' CEO Discusses Completion Of EoR Meeting With FDA For Northera Capsules NDA (Transcript) 05.23.12 | 07:05 am
- Chelsea Therapeutics' CEO Discusses Chelsea Therapeutics Receives Complete Response Letter From Food And Drug Administration For Northera(TM) (droxidopa) Capsules (Transcript) 03.29.12 | 01:03 pm
- Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest 03.23.12 | 05:03 am
- The Next Big Thing in Biotech: FDA Decisions
03.23.12 | 05:03 am - Biotech Stock Chat: Recap 03.15.12 | 11:03 am
- Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.06.12 | 07:03 pm
- Chelsea Therapeutics' CEO Presents FDA Advisory Committee Update - Conference Call (Transcript) 02.29.12 | 09:02 pm
- Wednesday's Top 10 Articles, Videos on TheStreet 02.29.12 | 01:02 pm
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Monday's Top 10 Articles, Videos on TheStreet 02.27.12 | 02:02 pm
Press Releases for CHTP
- Faruqi & Faruqi, LLP Notifies Investors Of June 4, 2012 Lead Plaintiff Deadline For The Class Action Filed Against Chelsea Therapeutics International - PR Newswire 05.29.12 | 07:05 pm
- Chelsea Therapeutics International Lead Plaintiff Deadline - June 4, 2012: Levi & Korsinsky Reminds Investors With Losses On Their Investment In Chelsea Therapeutics International Of Class Action And The Lead Plaintiff Deadline - Business Wire 05.29.12 | 02:05 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - PR Newswire 05.21.12 | 02:05 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.30.12 | 04:04 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Chelsea Therapeutics International, Ltd. To Contact The Firm - PR Newswire 04.20.12 | 07:04 pm
- Chelsea Therapeutics International Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Chelsea Therapeutics International, Ltd. - Business Wire 04.11.12 | 10:04 am
- Faruqi & Faruqi, LLP Announces Investigation Of Chelsea Therapeutics International, Ltd. - PR Newswire 04.05.12 | 07:04 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.05.12 | 04:04 pm
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Chelsea Therapeutics International, Ltd. - Business Wire 04.05.12 | 12:04 pm
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Chelsea Therapeutics International, Ltd. - Business Wire 02.21.12 | 08:02 am
Partner Headlines for CHTP
- How To Play Chelsea Therapeutics - Seeking Alpha 03.09.12 | 04:03 pm
- 5 High-Risk, High-Reward Biopharma Stocks - Seeking Alpha 02.14.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- Friday Options Recap - Seeking Alpha 12.23.11 | 03:12 pm
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
- Top 30 Rallying Small Cap Stocks With Significant Institutional Buying - Seeking Alpha 06.29.11 | 09:06 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 6 Cash Rich Biotech Stocks With Catalysts - Seeking Alpha 04.08.11 | 08:04 am
